Bipolar II disorder: Once missed, now dismissed, time to resist

Parker, Gordon

doi:10.1111/bdi.13174

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The essential controversy seems to be whether to use a dimensional or a categorical model of BD. Those who favor a dimensional model have argued that BP-II disorder has to be subsumed under the broader bipolar spectrum diagnosis[ 70 , 99 , 112 - 114 ], whereas others who favor a categorical approach maintain that there is sufficient evidence for an independent BP-II category[ 115 - 119 ]. The actual evidence in terms of validators provides almost equal support for both the dimensional and the categorical approaches.…”

Section: Summary Of the Changes Madementioning

confidence: 99%

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Chakrabarti¹

2022

World J Psychiatry

View full text Add to dashboard Cite

The World Health Organization’s 11 th revision of the International Classification of Diseases (ICD-11) including the chapter on mental disorders has come into effect this year. This review focuses on the “Bipolar or Related Disorders” section of the ICD-11 draft. It describes the benchmarks for the new version, particularly the foremost principle of clinical utility. The alterations made to the diagnosis of bipolar disorder (BD) are evaluated on their scientific basis and clinical utility. The change in the diagnostic requirements for manic and hypomanic episodes has been much debated. Whether the current criteria have achieved an optimum balance between sensitivity and specificity is still not clear. The ICD-11 definition of depressive episodes is substantially different, but the lack of empirical support for the changes has meant that the reliability and utility of bipolar depression are relatively low. Unlike the Diagnostic and Statistical Manual of Mental Disorders, 5 th edition (DSM-5), the ICD-11 has retained the category of mixed episodes. Although the concept of mixed episodes in the ICD-11 is not perfect, it appears to be more inclusive than the DSM-5 approach. Additionally, there are some uncertainties about the guidelines for the subtypes of BD and cyclothymic disorder. The initial results on the reliability and clinical utility of BD are promising, but the newly created diagnostic categories also appear to have some limitations. Although further improvement and research are needed, the focus should now be on facing the challenges of implementation, dissemination, and education and training in the use of these guidelines.

show abstract

Section: Summary Of the Changes Madementioning

confidence: 99%

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Chakrabarti¹

2022

World J Psychiatry

View full text Add to dashboard Cite

show abstract

“…However, studies that recruited both patients with BD I and BD II found that psychotic symptoms were associated with a higher frequency of a first diagnosis different from BD or major depressive disorder (MDD), a prevalent manic polarity, and a higher number of lifetime manic episodes (more than six) [ 23 ]. Given that previous studies have frequently reported differences in clinicodemographic factors, including psychotic features between patients with BD I and BD II [ 24 , 25 ], it is possible that patients’ different types of diagnosis may contribute to the inconsistent results.…”

Section: Introductionmentioning

confidence: 99%

Clinicodemographic correlates of psychotic features in bipolar disorder – a multicenter study in China

et al. 2023

View full text Add to dashboard Cite

Background Psychotic symptoms are prevalent in patients with bipolar disorder (BD). However, nearly all previous studies on differences in sociodemographic and clinical factors between patients with (BD P +) and without (BD P-) psychotic symptoms were conducted in Western populations, and limited information is known in China. Method A total of 555 patients with BD from seven centers across China were recruited. A standardized procedure was used to collect patients’ sociodemographic and clinical characteristics. The patients were divided into BD P + or BD P- groups based on the presence of lifetime psychotic symptoms. Mann–Whitney U test or chi-square test was used to analyze differences in sociodemographic and clinical factors between patients with BD P + and BD P-. Multiple logistic regression analysis was conducted to explore factors that were independently correlated with psychotic symptoms in BD. All the above analyses were re-conducted after the patients were divided into BD I and BD II group according to their types of diagnosis. Results A total of 35 patients refused to participate, and the remaining 520 patients were included in the analyses. Compared with patients with BD P-, those with BD P + were more likely to be diagnosed with BD I and mania/hypomania/mixed polarity in the first mood episode. Moreover, they were more likely to be misdiagnosed as schizophrenia than major depressive disorder, were hospitalized more often, used antidepressants less frequently, and used more antipsychotics and mood stabilizers. Multivariate analyses revealed that diagnosis of BD I, more frequent misdiagnosis as schizophrenia and other mental disorders, less frequent misdiagnosis as major depressive disorder, more frequent lifetime suicidal behavior, more frequent hospitalizations, less frequent use of antidepressants, more frequent use of antipsychotics and mood stabilizers were independently correlated with psychotic symptoms in BD. After dividing the patients into BD I and BD II groups, we observed notable differences in sociodemographic and clinical factors, as well as clinicodemographic correlates of psychotic features between the two groups. Conclusions Differences in clinical factors between patients with BD P + and BD P- showed cross-cultural consistency, but results on the clinicodemographic correlates of psychotic features were not. Notable differences between patients with BD I and BD II were found. Future work exploring the psychotic features of BD needs to take types of diagnosis and cultural differences into consideration. Trial registration This study was first registered on the website of the ClinicalTrials.gov (https://clinicaltrials.gov/) on 18/01/2013. Its registration number is NCT01770704.

show abstract

Bipolar II disorder: Once missed, now dismissed, time to resist

Cited by 2 publications

References 5 publications

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Clinicodemographic correlates of psychotic features in bipolar disorder – a multicenter study in China

Contact Info

Product

Resources

About